The phase III NETTER-1 study of 177Lu-DOTATATE in patients with midgut neuroendocrine tumours: Further survival analyses Meeting Abstract


Authors: Ruszniewski, P. B.; Caplin, M. E.; Kunz, P. L.; Bodei, L.; Hendifar, A. E.; Mittra, E.; Wolin, E. M.; Yao, J. C.; Pavel, M. E.; Grande, E.; Van Cutsem, E.; Seregni, E.; Duarte, H.; Demange, A.; Mutevelic, S.; Krenning, E. P.; Strosberg, J. R.
Abstract Title: The phase III NETTER-1 study of 177Lu-DOTATATE in patients with midgut neuroendocrine tumours: Further survival analyses
Meeting Title: ESMO Congress 2021
Journal Title: Annals of Oncology
Volume: 32
Issue: Suppl. 5
Meeting Dates: 2021 Sep 16-21
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2021-09-01
Start Page: S911
End Page: S912
Language: English
ACCESSION: WOS:000700527702120
DOI: 10.1016/j.annonc.2021.08.184
PROVIDER: wos
Notes: Meeting Abstract #1102P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lisa   Bodei
    210 Bodei